ReviewPharmacological reports : PR2021

Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes.

Harpinder Kaur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.